EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudieOpen Access · CC BY-NC 4.0

Effectiveness of JAK Inhibitors Compared With Biologic Disease‐Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study

Anna Eberhard iD, Daniela Di Giuseppe, Johan Askling, Stefan Bergman, Hannah Bower, Katerina Chatzidionysiou iD, Helena Forsblad-d'Elia, Alf Kastbom iD, Tor Olofsson iD, Thomas Frisell, Carl Turesson iD

Arthritis & Rheumatology · 2025

DOI: 10.1002/art.43014 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Arthritis & Rheumatology, 2025. Verfasst von Anna Eberhard und 10 weiteren Autor:innen. Beteiligte Einrichtung: Lund University, Malmö, Sweden. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Antirheumatic Agents, Janus Kinase Inhibitors, Biological Products. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Lund University, Swedish Research Council, Swedish Rheumatism Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare the effectiveness of JAK inhibitors (JAKis) and biologic disease‐modifying antirheumatic drugs (bDMARDs) on pain in patients with rheumatoid arthritis.

Methods

In this retrospective study, we investigated patients with a diagnosis of rheumatoid arthritis, starting treatment with a JAKi (n = 1,827), a tumor necrosis factor inhibitor (TNFi; n = 6,422), an interleukin‐6 inhibitor (n = 887), abatacept (n = 1,102), or rituximab (n = 1,149) in 2017 to 2019, using data from several linked Swedish national registers. Differences in change in pain, assessed with a visual analog scale (0–100 mm), from baseline to 3 months, as well as proportions of patients remaining on initial treatment with low pain (visual analog scale pain

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidAntirheumatic AgentsJanus Kinase InhibitorsBiological ProductsHumansFemaleMaleMiddle AgedRetrospective StudiesSwedenAgedTreatment OutcomeTumor Necrosis Factor InhibitorsAbataceptRituximabPain MeasurementAdult

Substanzen

Antirheumatic AgentsJanus Kinase InhibitorsTumor Necrosis Factor InhibitorsAbataceptRituximabBiological Products

Autor:innen und Institutionen

  • Lund University, Malmö, Sweden.
  • Karolinska Institutet, Stockholm, Sweden.
  • Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
  • Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Linköping University, Linköping, Sweden.

ORCID-Profile: Anna Eberhard, Katerina Chatzidionysiou, Alf Kastbom, Tor Olofsson, Carl Turesson

Förderung

  • Lund University
  • Swedish Research Council
  • Swedish Rheumatism Association

Zitieren

APA

Eberhard, A., Di Giuseppe, D., Askling, J., Bergman, S., Bower, H., Chatzidionysiou, K., Forsblad-d'Elia, H., Kastbom, A., Olofsson, T., Frisell, T., & Turesson, C. (2025). Effectiveness of JAK Inhibitors Compared With Biologic Disease‐Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study. Arthritis & Rheumatology. https://doi.org/10.1002/art.43014

Vancouver

Eberhard A, Di Giuseppe D, Askling J, Bergman S, Bower H, Chatzidionysiou K, et al. Effectiveness of JAK Inhibitors Compared With Biologic Disease‐Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study. Arthritis & Rheumatology. 2025. doi:10.1002/art.43014

BibTeX
@article{Eberhard2025,
  author = {Eberhard, Anna and Di Giuseppe, Daniela and Askling, Johan and Bergman, Stefan and Bower, Hannah and Chatzidionysiou, Katerina and Forsblad-d'Elia, Helena and Kastbom, Alf and Olofsson, Tor and Frisell, Thomas and Turesson, Carl},
  title = {Effectiveness of JAK Inhibitors Compared With Biologic Disease‐Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study},
  journal = {Arthritis & Rheumatology},
  year = {2025},
  doi = {10.1002/art.43014}
}
Kostenlos starten →